TrialProceedings of the National Academy of Sciences of the United States of America1996

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

E G Hanania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.